Headline
The latest stories from AHA Today.
The AHA announced it is honoring five hospital-led partnerships with the AHA Dick Davidson NOVA Award for each program’s efforts to improve community health.
Leaders of the Black Maternal Health Caucus virtually convened the second annual Stakeholder Summit, where members of Congress and supporting organizations urged passage of the Black Maternal Health Momnibus Act (H.R. 6142/S. 3424) to end preventable maternal mortality and severe maternal morbidity…
President Trump signed three executive orders aimed at lowering the price of prescription drugs, with actions targeting federally qualified health center insulin and EpiPen discounts; the importation and re-importation of prescription drugs from foreign countries; and drug manufacturer rebates and…
Saint Anthony Hospital, a safety-net hospital in Chicago, through its Community Wellness Programs has continued to provide free mental health services targeting minority and immigrant populations despite challenges due to COVID-19.
Atrium Health President and CEO Eugene Woods spoke on CBS’s Face the Nation about the lack of reagents for COVID-19 testing, racial disparities during the pandemic and treating thousands of COVID-19 patients in their homes.
Hologic Inc. received $7.6 million from the Department of Health and Human Services and Department of Defense to increase production of supplies needed for COVID-19 testing, including custom sample collection and processing consumables.
The National Institutes of Health announced that a COVID-19 vaccine candidate co-developed by Moderna, Inc. and the National Institute of Allergy and Infectious Diseases has begun a phase 3 clinical trial.
The Food and Drug Administration reissued its emergency use authorization for the LabCorp COVID-19 RT-PCR Test to include authorized use for asymptomatic individuals and for pooled sample testing with up to five individual specimens.
The Food and Drug Administration updated its resource for labs performing authorized COVID-19 tests.
The Food and Drug Administration required updated labeling for opioid pain medicine and medicine to treat opioid use disorder to recommend that prescribers discuss naloxone with patients and caregivers.